another CBD product. http://finance.yahoo.com/new

PLANO, TX--(Marketwired - Mar 19, 2014) - Polaris International Holdings, Inc. (PINKSHEETS: PIHN) (OTC Pink: PIHN) is pleased to announce they have entered into an exclusive agreement with Longevity Holdings, LLC for the ProCannas® product line. The agreement grants the sole rights to sell, distribute and market the provisional patent-pending formulation of Longevity Holding, LLC cannabis oil. The ProCannas® line is unique due to the blend of cannabinoids, vitamins, antioxidants, and other proven ingredients to be used for medicinal purposes. The full ProCannas® Line will include liquid drops for ingestion, tablets, and transdermal patches. The oils used in these formulations are high quality pharmaceutical grade and will only be available through licensed participating physicians.

Extensive Research has been conducted in order to arrive at this unique formulation which is void of THC and other psychotropic components. Many independent studies have shown that various formulations of cannabinoids help to prevent cancer and promote overall health without the need for THC. Such formulations are being used regularly in India and date back over 5,000 years as part of Eastern Medicine disciplines.